GI Symptoms Persist in Most Female Colorectal Cancer Survivors
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Aug. 9, 2023 -- Female colorectal cancer (CRC) survivors experience a high burden of gastrointestinal (GI) symptoms, according to a study recently published in PLOS ONE.
Claire J. Han, from The Ohio State University in Columbus, and colleagues used data from the Women’s Health Initiative Life and Longevity After Cancer study to characterize persistent GI symptoms after cancer treatments among 413 female CRC survivors.
The researchers found that during a mean 8.1 years since diagnosis, 81 percent of CRC survivors experienced persistent GI symptoms, including most commonly bloating/gas (54.2 percent), followed by constipation (44.1 percent), diarrhea (33.4 percent), and abdominal/pelvic pain (28.6 percent). Time since cancer diagnosis (less than five years), advanced cancer stage, high psychological distress, poor dietary habits, and low physical activity were significant risk factors for GI symptoms. For long-term GI symptoms, fatigue and sleep disturbance were the most significant risk factors (β = 0.21 and β = 0.20, respectively). There were positive associations observed between high severity of GI symptoms and poor quality of life, increased daily life interferences (social and physical functions), and low body image satisfaction.
"GI symptoms among survivors have been underinvestigated in the past, but we found that they are very prevalent even up to 25 years after diagnosis, suggesting it's very important to consider GI symptom management as part of their survivorship care," Han said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Diagnosis of Early-Onset Colorectal Cancer Often Delayed
WEDNESDAY, May 29, 2024 -- Nearly half of individuals diagnosed with early-onset colorectal cancer (EOCRC) present with hematochezia and abdominal pain, and one-quarter present...
Offering Choice of CRC Screening Increases Completion Rates
TUESDAY, May 21, 2024 -- For adults who are not up to date with colorectal cancer screening, offering a choice of colonoscopy or fecal immunochemical testing (FIT) increases...
DDW: 1999 to 2020 Saw Rise in Incidence of Colorectal Cancer in People Under 45
MONDAY, May 13, 2024 -- For individuals aged younger than 45 years, the incidence of colorectal cancer increased considerably from 1999 to 2020, with a 333 percent increase among...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.